Green Planet Bioengineering Co(GPLB)
$0.030.00 (0.00%)
GPLB
Green Planet Bioengineering Co financials statements
$0.03
At close:0.00 (0.00%)
Green Planet Bioengineering Co (GPLB) Ratios
8 Followers
Green Planet Bioengineering Co Ratios
GPLB's free cash flow for Q2 2026 was $-12.65K. For the 2026 fiscal year, GPLB's free cash flow was increased by $0.00 and operating cash flow was $-12.65K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quick Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Solvency Ratio | -0.07 | -0.08 | -0.11 | 0.51 | 0.58 |
| Operating Cash Flow Ratio | -0.07 | -6.37 | -8.53 | 0.00 | 0.00 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -500.98K | $ -465.13K | $ -429.59K | $ -381.92K | $ -349.39K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | -157.90 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | -157.90 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 100.00% | 100.00% | 100.63% | 100.00% | 100.00% |
| Return on Assets (ROA) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Return on Equity (ROE) | 7.15% | 7.64% | 11.10% | 8.52% | 9.42% |
| Return on Capital Employed (ROCE) | 7.15% | 646.25% | 947.40% | 0.00% | 0.00% |
| Return on Invested Capital (ROIC) | 7.15% | 646.25% | 947.40% | 0.00% | 0.00% |
| Return on Tangible Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Earnings Yield | -14.33% | -0.33% | -3.91% | -0.07% | -0.91% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -14.61% | -0.32% | -3.50% | -0.07% | -0.91% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -6.94 | -300.00 | -25.60 | -1482.02 | -109.36 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -0.50 | -23.23 | -2.84 | -126.24 | -10.31 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -6.84 | -308.28 | -28.60 | -1482.02 | -109.36 |
| Price-to-Operating Cash Flow Ratio | -6.84 | -308.28 | -28.60 | -1482.02 | -109.36 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 12.00 | -0.51 | 0.00 | 18.59 |
| Enterprise Value Multiple | -6.98 | -303.94 | -25.76 | 246.05 | 17.68 |
| Enterprise Value | 250.08K | 10.80M | 1.22M | 48.21M | 3.60M |
| EV to EBITDA | -6.98 | -303.94 | -25.76 | 246.05 | 17.68 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -6.84 | -308.28 | -28.60 | -1482.02 | -109.36 |
| EV to Operating Cash Flow | -6.84 | -308.28 | -28.60 | -1482.02 | -109.36 |
| Tangible Book Value Per Share | -0.03 | -0.02 | -0.02 | -0.02 | -0.02 |
| Shareholders’ Equity Per Share | -0.03 | -0.02 | -0.02 | -0.02 | -0.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.01 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.02 | 0.99 | 0.90 | 1.00 | 1.00 |
Currency in USD

